2 Result: Abcam
Breaking: Abcam to be Acquired by Danaher; Setback for NovoCure
August 28th, 2023
Abcam plc (Nasdaq: ABCM) has agreed to be acquired by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The transaction has received unanimous approval from both Abcam's and Danaher's Boards of Directors. In pre-market, $ABCM is tra. Read more
Lucintel Forecasts Epigenetic Market to grow at a CAGR of 14% from 2019 to 2024
December 08th, 2021
Dallas, TX / CRWE PRESS RELEASE / Dec. 9, 2021 - According to the recent study the Epigenetic Market is projected to grow at a CAGR of 14% from 2019 to 2024. Growth in this market is primarily driven by declining sequencing costs and time, incre. Read more
Want To Find Some News?
Recent Post
-
Countdown to Earnings: Qualcomm, McKesson, and Humana Take the Stage
November 03rd, 2025Earnings Preview: DoorDash, Cencora, and Fortinet in Focus
November 03rd, 2025Wall Street Eyes Palantir, Diamondback, and Hologic Ahead of Earnings
November 02nd, 2025Crown Equity Holdings, Inc. Announces Dissolution of Partnership with Herbal Works Inc.
November 02nd, 2025Cadence Design Systems, Celestica, and F5 Earnings Preview
October 26th, 2025
Member Login